These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9792245)
21. Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration. Ikemoto K; Nishimura A; Okado N; Mikuni M; Nishi K; Nagatsu I Brain Res; 2000 Jan; 853(2):377-80. PubMed ID: 10640637 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of tyrosine hydroxylase and concentrations of monoamines in the substantia nigra and hypothalamus of hereditary microphthalmic rats. Shim SH; Kim SJ; Sugahara K; Sugita S; Tanaka H Exp Anim; 2001 Oct; 50(5):445-9. PubMed ID: 11769550 [TBL] [Abstract][Full Text] [Related]
23. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity. Gili A; Thomas PD; Ota M; Jimbow K Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635 [TBL] [Abstract][Full Text] [Related]
24. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932 [TBL] [Abstract][Full Text] [Related]
25. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey. Smith Y; Charara A; Parent A J Comp Neurol; 1996 Jan; 364(2):231-53. PubMed ID: 8788247 [TBL] [Abstract][Full Text] [Related]
26. Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease. Hirsch EC; Graybiel AM; Agid Y Acta Neurol Scand Suppl; 1989; 126():19-22. PubMed ID: 2575832 [TBL] [Abstract][Full Text] [Related]
27. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Zecca L; Shima T; Stroppolo A; Goj C; Battiston GA; Gerbasi R; Sarna T; Swartz HM Neuroscience; 1996 Jul; 73(2):407-15. PubMed ID: 8783258 [TBL] [Abstract][Full Text] [Related]
28. Specific visualization of neuromelanin-iron complex and ferric iron in the human post-mortem substantia nigra using MR relaxometry at 7T. Lee H; Baek SY; Chun SY; Lee JH; Cho H Neuroimage; 2018 May; 172():874-885. PubMed ID: 29162523 [TBL] [Abstract][Full Text] [Related]
29. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease. Gai WP; Vickers JC; Blumbergs PC; Blessing WW J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1039-46. PubMed ID: 7916375 [TBL] [Abstract][Full Text] [Related]
30. The aging substantia nigra: quantitative histologic study. Faraldi F; Reyes MG; Alfieri E; Levi AC Panminerva Med; 1994 Sep; 36(3):103-8. PubMed ID: 7877822 [TBL] [Abstract][Full Text] [Related]
31. Dolichol is the major lipid component of human substantia nigra neuromelanin. Fedorow H; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B J Neurochem; 2005 Feb; 92(4):990-5. PubMed ID: 15686500 [TBL] [Abstract][Full Text] [Related]
32. Urocortin-like immunoreactivity in the substantia nigra, ventral tegmental area and Edinger-Westphal nucleus of rat. Yamamoto H; Maeda T; Fujimura M; Fujimiya M Neurosci Lett; 1998 Feb; 243(1-3):21-4. PubMed ID: 9535103 [TBL] [Abstract][Full Text] [Related]
33. Glia protects neurons against extracellular human neuromelanin. Depboylu C; Matusch A; Tribl F; Zoriy M; Michel PP; Riederer P; Gerlach M; Becker S; Oertel WH; Höglinger GU Neurodegener Dis; 2007; 4(2-3):218-26. PubMed ID: 17596716 [TBL] [Abstract][Full Text] [Related]
34. Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes. Wulf M; Barkovits K; Schork K; Eisenacher M; Riederer P; Gerlach M; Eggers B; Marcus K J Neural Transm (Vienna); 2022 Oct; 129(10):1257-1270. PubMed ID: 35852604 [TBL] [Abstract][Full Text] [Related]
35. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons. Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721 [TBL] [Abstract][Full Text] [Related]
36. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia Nigra. Haber SN; Groenewegen HJ J Comp Neurol; 1989 Dec; 290(1):53-68. PubMed ID: 2480370 [TBL] [Abstract][Full Text] [Related]
37. Cysteinyldopamine is not incorporated into neuromelanin. Wakamatsu K; Ito S; Nagatsu T Neurosci Lett; 1991 Sep; 131(1):57-60. PubMed ID: 1791980 [TBL] [Abstract][Full Text] [Related]
38. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study. Nemoto C; Hida T; Arai R Brain Res; 1999 Oct; 846(1):129-36. PubMed ID: 10536220 [TBL] [Abstract][Full Text] [Related]
39. Subpopulations of neurons in rat substantia nigra display GABA(B)R2 receptor immunoreactivity. Ng TK; Yung KK Brain Res; 2001 Nov; 920(1-2):210-6. PubMed ID: 11716827 [TBL] [Abstract][Full Text] [Related]
40. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Damier P; Hirsch EC; Agid Y; Graybiel AM Brain; 1999 Aug; 122 ( Pt 8)():1421-36. PubMed ID: 10430829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]